+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
COLINZ COLINZ

Colinz Laboratories Share Price

₹73.50 -3.19 (-4.16%)
103.54% Gain from 52W Low

01 Oct, 2026 4:01 PM (IST)

Colinz Laboratories live price: ₹73.50. It opened at ₹74 vs previous close ₹77; intraday high/low: ₹74/₹73. The 50 & 200 DMA stand at ₹74.00/₹63.20.

Colinz Laboratories Performance

  • Today's Low
  • ₹73
  • Today's High
  • ₹74
  • 52 Week Low
  • ₹36
  • 52 Week High
  • ₹88
  • Open Price₹74
  • Previous Close₹77
  • Volume2,711
  • 50 DMA₹74.00
  • 100 DMA₹69.80
  • 200 DMA₹63.20

Colinz Laboratories Chart

Investment Returns

  • Over 1 Month + 2.8%
  • Over 3 Month -5.22%
  • Over 6 Month + 68.15%
  • Over 1 Year + 68%

Smart Investing Starts Here Start SIP with Colinz Laboratories for Steady Growth!

Invest Now

Colinz Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.6
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 19
  • P/B Ratio
  • 1.5
  • Average True Range
  • 4.3
  • EPS
  • 11.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 47.67
  • MFI
  • 41.87

Latest Stock News Updates

Colinz Laboratories Ltd - 531210 - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue, Rights Issue, Preferential Issue, QIP) For The Quarter Ended 30.09.2026.

Dear Sir, PFA, attached Certificate under Regulation 32 of SEBI(LODR) Regulation,2015 and Statement of Deviation or Variation is NOT applicable to the Company for the Quarter Ended on 30-9-2026. Kindly take the same on records. For Colinz Labs Ltd Director

Colinz Laboratories Ltd - 531210 - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements, Regulation 2015).

Dear Sir, Pursuant to Regulations23(9) of SEBI (LODR). Regulations,2015, the said Regulation is not applicable to us, Kindly take the Non-Applicability Certificate on records for Quarter Ending on 30-9-2026. FOr Colinz Labs Ltd Director 01-10-2026

Colinz Laboratories Ltd - 531210 - Closure of Trading Window

We would like to inform you that pursuant to the COmpanys Act and SEBI(PIT), Regulation, 2015 The Trading Window for Designated Persons and KMPS will remain closed form 1-10-26 to till 48 hours after the announcement of Financial Results for the Quarter ended 30-9-2026. Kindly take the same on records. for Colinz Labs Ltd Vijaya Mani

Colinz Laboratories Financials

Colinz Laboratories Technicals

EMA & SMA

Current Price
₹73.50
-3.19 (-4.16%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹74.50
  • 50 Day
  • ₹74.00
  • 100 Day
  • ₹69.80
  • 200 Day
  • ₹63.20

Resistance and Support

73.37 Pivot Speed
  • R3 74.20
  • R2 73.90
  • R1 73.70
  • S1 73.20
  • S2 72.80
  • S3 72.60

Colinz Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-30 Quarterly Results
2026-04-29 Quarterly Results
2026-01-24 Quarterly Results
2026-01-17 Others
2025-11-27 Others Inter-alia to approve appointment of Ms. Falguni Kumawat as the Company Secretary and Compliance Officer of the Company and Key Managerial Personnel of the Company.

Colinz Laboratories Shareholding Pattern

50.6%
49.39%
0%

Colinz Laboratories FAQs

Colinz Laboratories share price is ₹73 As on 04 October, 2026 | 09:49

The Market Cap of Colinz Laboratories is ₹18.5 Cr As on 04 October, 2026 | 09:49

The P/E ratio of Colinz Laboratories is 6.6 As on 04 October, 2026 | 09:49

The PB ratio of Colinz Laboratories is 1.5 As on 04 October, 2026 | 09:49

The 52 week High & Low of Colinz Laboratories is ₹87.9/₹36.1 respectively As on 04 October, 2026 | 09:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23